Alpha 1-adrenoceptor blocking activities of bevantolol hydrochloride(NC-1400) and labetalol in rat isolated thoracic aorta--do they distinguish between subtypes?

[1]  M. Satoh,et al.  Differences in alpha 1-adrenoceptor mechanisms for phenylephrine and tizanidine in rabbit thoracic aorta and common iliac artery. , 1991, Canadian journal of physiology and pharmacology.

[2]  K. Minneman,et al.  Subtypes of α1adrenoceptors in rat blood vessels , 1990 .

[3]  G. Tsujimoto,et al.  Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role. , 1990, Molecular pharmacology.

[4]  P. Abel,et al.  Heterogeneity of alpha 1-adrenergic receptors revealed by chlorethylclonidine. , 1987, Molecular pharmacology.

[5]  I. Takayanagi,et al.  (+/-)-1-[[2-(3,4-Dimethoxphenyl)ethyl]amino]-3-(3-methylphenoxy)-2- propanol hydrochloride (bevantolol, NC-1400) as a beta 1-selective adrenoceptor blocker with alpha 1-adrenoceptor blocking activity. , 1987, General pharmacology.

[6]  I. Creese,et al.  Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. , 1986, Molecular pharmacology.

[7]  N. Flavahan,et al.  α1-Adrenoceptor subclassification in vascular smooth muscle , 1986 .

[8]  I. Takayanagi,et al.  Newly synthesized α1-adrenoceptor blockers (SM911 and SM2470) and characterization of α-adrenoceptors in rat aortic strips, rat vas deferens preparations and rabbit aortic strips , 1985 .

[9]  R. Summers,et al.  Characterization of postsynaptic α‐adrenoceptors in rat aortic strips and portal veins , 1983 .

[10]  H. Schild,et al.  SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.